Quantcast

Latest narcolepsy Stories

2010-10-26 13:39:20

Ever wonder why some people breeze along on four hours of sleep when others can barely function? It may be in our genes, according to new research and an accompanying editorial published in the October 26, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at people who have a gene variant that is closely associated with narcolepsy, a sleep disorder that causes excessive daytime sleepiness. However, having the gene...

2010-10-26 11:10:43

(Ivanhoe Newswire) -- Have you ever wondered how some people go about their busy days on only 4 hours of sleep while others need at least 8 to function? This study suggests that genes may play a role in how the amount of sleep we get affects us. The study examined people who have a gene variant that is closely associated with narcolepsy, a sleep disorder that causes excessive daytime sleepiness. Having the gene variant, called DQB1*0602, doesn't mean that a person will develop narcolepsy....

2010-10-22 15:38:00

FRAZER, Pa., Oct. 22 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL® (armodafinil) Tablets [C-IV] and PROVIGIL® (modafinil) Tablets [C-IV] have been approved by the U.S. Food and Drug Administration (FDA). Both the NUVIGIL and PROVIGIL REMS consist of a Medication Guide to inform patients about the potential risks associated with the use of these...

2010-10-20 07:00:00

SAN DIEGO, Oct. 20, 2010 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today results from a Phase 1 clinical trial of APD916, a novel drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy with cataplexy. The randomized, double-blind and placebo-controlled trial evaluated the safety, tolerability and pharmacokinetics of 1 mg, 3 mg and 5 mg single doses of APD916. The trial evaluated 24 healthy volunteers...

53e8d6f1c5fe4715c0cc2ba2f1e70d181
2010-08-28 07:30:00

Concerns among officials in Finland and Sweden over possible links between narcolepsy and the Pandemrix swine flu vaccine have caused the European Medicines Agency (EMA) to launch an investigation into the matter. "The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigate whether there is a link between cases of narcolepsy and vaccination with Pandemrix," said the EMA. The London-based agency added that only a handful of cases...

2010-06-08 18:44:09

Regulations that limit the number of hours worked also should provide guidance for shift start times to maximize workers' sleep opportunity and minimize the risk of on-the-job fatigue, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that estimated sleep durations varied from 4.5 hours to eight hours according to the start time...

2010-06-08 18:40:25

Excessive sleepiness is more common in the U.S. than in Europe, which raises concerns for public health and safety, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that 19.5 percent of U.S. adults reported having moderate to excessive sleepiness, which was comparable between men and women.  Furthermore, 11 percent of...

2010-06-08 18:38:42

A small percentage of nurses struggle to remain vigilant during successive 12-hour shifts, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that lapses of attention among nurses working successive 12-hour shifts ranged from zero to 48 lapses per vigilance test. Although half of nurses committed no more than one lapse, 10 percent...

2010-06-07 13:28:18

Although incident parasomnias are uncommon as children enter adolescence, parasomnias present in preadolescents may persist into the teen years, according to a research abstract that will be presented Monday, June 7, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that the rate of persistence after five years was 29 percent for children with bedwetting and 27 percent for children with...

2010-04-27 21:15:00

WORCESTER, Mass., April 27 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy (WUN), a non-profit foundation started in 2008 by Kevin Cosgrove, a 32-year-old with narcolepsy, had 4 runners participating in the April 19, 2010 Boston marathon. The mission of WUN is to promote and foster education and awareness about narcolepsy in order to one day find a cure for this sleep disorder that affects 200,000 people in the United States. Narcolepsy is a chronic neurological disorder caused by the...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related